Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
文献类型：期刊论文
| 作者 | He, Q.; Yu, X. |
| 刊名 | JOURNAL OF THORACIC ONCOLOGY
 |
| 出版日期 | 2021-03-01 |
| 卷号 | 16 |
| 关键词 | Immunotherapy Tislelizumab Esophageal Squamous Cell Carcinoma |
| ISSN号 | 1556-0864 |
| WOS研究方向 | Oncology ; Respiratory System |
| 语种 | 英语 |
| WOS记录号 | WOS:000631349600502 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/121735]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China 2.Dept Med Oncol, Hangzhou, Peoples R China 3.Chinese Acad Sci, Inst Canc & Basic Med Icbm, Hangzhou, Zhejiang, Peoples R China |
| 推荐引用方式 GB/T 7714 | He, Q.,Yu, X.. Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma[J]. JOURNAL OF THORACIC ONCOLOGY,2021,16. |
| APA | He, Q.,&Yu, X..(2021).Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.JOURNAL OF THORACIC ONCOLOGY,16. |
| MLA | He, Q.,et al."Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma".JOURNAL OF THORACIC ONCOLOGY 16(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。